These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 25226025)

  • 1. Adjunctive and long-acting nanoformulated antiretroviral therapies for HIV-associated neurocognitive disorders.
    Gendelman HE; Gelbard HA
    Curr Opin HIV AIDS; 2014 Nov; 9(6):585-90. PubMed ID: 25226025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-associated neurocognitive disorders (HAND).
    Elbirt D; Mahlab-Guri K; Bezalel-Rosenberg S; Gill H; Attali M; Asher I
    Isr Med Assoc J; 2015 Jan; 17(1):54-9. PubMed ID: 25739180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dementia and neurocognitive disorders due to HIV-1 infection.
    Ances BM; Ellis RJ
    Semin Neurol; 2007 Feb; 27(1):86-92. PubMed ID: 17226745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathogenesis of HIV-associated neurocognitive disorders: roles for immune activation, HIV blipping and viral tropism.
    Chen MF; Gill AJ; Kolson DL
    Curr Opin HIV AIDS; 2014 Nov; 9(6):559-64. PubMed ID: 25203638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV infection and the central nervous system: a primer.
    Ellis RJ; Calero P; Stockin MD
    Neuropsychol Rev; 2009 Jun; 19(2):144-51. PubMed ID: 19415500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review.
    Cysique LA; Brew BJ
    Neuropsychol Rev; 2009 Jun; 19(2):169-85. PubMed ID: 19424802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognitive disorders seen in HIV disease.
    Ungvarski PJ; Trzcianowska H
    Issues Ment Health Nurs; 2000; 21(1):51-70. PubMed ID: 10839052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 neuroimmunity in the era of antiretroviral therapy.
    Kraft-Terry SD; Stothert AR; Buch S; Gendelman HE
    Neurobiol Dis; 2010 Mar; 37(3):542-8. PubMed ID: 20044002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rodent models for HIV-associated neurocognitive disorders.
    Gorantla S; Poluektova L; Gendelman HE
    Trends Neurosci; 2012 Mar; 35(3):197-208. PubMed ID: 22305769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developments in Neuroprotection for HIV-Associated Neurocognitive Disorders (HAND).
    Kolson DL
    Curr HIV/AIDS Rep; 2022 Oct; 19(5):344-357. PubMed ID: 35867211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unravelling the triad of neuroinvasion, neurodissemination, and neuroinflammation of human immunodeficiency virus type 1 in the central nervous system.
    Calado M; Ferreira R; Pires D; Santos-Costa Q; Anes E; Brites D; Azevedo-Pereira JM
    Rev Med Virol; 2024 May; 34(3):e2534. PubMed ID: 38588024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment.
    Spudich S; González-Scarano F
    Cold Spring Harb Perspect Med; 2012 Jun; 2(6):a007120. PubMed ID: 22675662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of HIV in the central nervous system.
    Valcour V; Sithinamsuwan P; Letendre S; Ances B
    Curr HIV/AIDS Rep; 2011 Mar; 8(1):54-61. PubMed ID: 21191673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The brain and HAART: collaborative and combative connections.
    Meeker RB; Asahchop E; Power C
    Curr Opin HIV AIDS; 2014 Nov; 9(6):579-84. PubMed ID: 25275707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating HIV Infection in the Central Nervous System.
    Calcagno A; Di Perri G; Bonora S
    Drugs; 2017 Feb; 77(2):145-157. PubMed ID: 28070871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between ageing and NeuroAIDS.
    Hellmuth J; Milanini B; Valcour V
    Curr Opin HIV AIDS; 2014 Nov; 9(6):527-32. PubMed ID: 25203641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of advanced HIV disease: resistance, antiretroviral brain penetration and malignancies.
    Boffito M; Pillay D; Wilkins E
    Int J Clin Pract; 2006 Sep; 60(9):1098-106. PubMed ID: 16939552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies.
    Ances BM; Clifford DB
    Curr Neurol Neurosci Rep; 2008 Nov; 8(6):455-61. PubMed ID: 18957181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baricitinib reverses HIV-associated neurocognitive disorders in a SCID mouse model and reservoir seeding in vitro.
    Gavegnano C; Haile WB; Hurwitz S; Tao S; Jiang Y; Schinazi RF; Tyor WR
    J Neuroinflammation; 2019 Sep; 16(1):182. PubMed ID: 31561750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.
    Christo PP; Greco DB; Aleixo AW; Livramento JA
    BMC Infect Dis; 2007 Dec; 7():147. PubMed ID: 18096083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.